Abstract:Purpose: To investigate the efficacy, safety, and mechanisms of Sirolimus sustained delivery film on prevention of scar formation in a rabbit model of glaucoma filtration surgery.Methods: Sixty-four New Zealand white rabbits who underwent trabeculectomy in the right eye were randomly allocated to one of the four treatment regimens: Sirolimus sustained delivery film treatment group (Group A), or drug-free film treatment group (Group B), or 30 ng/ml Sirolimus-soaked sponge treatment group (Group C), or no adjunctive treatment group (Group D), and each group consists of 16 rabbits. Intraocular pressure (IOP), morphologic changes of bleb, anterior chamber flare, and corneal endothelial cell count and complications were evaluated over a 28-day period follow-up time. Aqueous humor samples were gathered from Group A, and the concentration of Sirolimus was measured regularly post-operation. Rabbits were sacrificed on the 7th, 14th, and 28th day post-operation separately, and the fibroblast hypertrophy, infiltration of inflammatory, and proliferation of new collagen fiber formation in each group were evaluated with HE and Masson staining. Proliferative cell nuclear antigen (PCNA) and fibroblast apoptosis were evaluated by immunohistochemistry and terminal deoxynucleotidyl transferasemediated dUTP nick end labeling (TUNEL) assay at the 28th day post-operation.Results: Both Sirolimus sustained delivery film (Group A) and Sirolimus alone (Group C) were well tolerated in this model, and significantly prolonged bleb survival compared with no drug treatment group (Group B and D; p<0.001). Group A had the longest bleb survival time in comparison with other groups (p<0.001). There were significant differences in IOP readings between Group A and other groups at the last follow-up (p<0.05). The concentration of Group A maintained stable for over 2 weeks, drops from (10.56 +/- 0.05) ng/ml at day 3 to (7.74 +/- 0.05) ng/ml at day 14. The number of corneal endothelial cells of Group A was not statistically significant between pre and post-operation. Histologic examination demonstrated that eyes treated with Sirolimus, especially the Sirolimus sustained delivery film, showed an obvious reduction in subconjunctival fibroblast scar tissue formation compared with no drug treatment groups, and had minimal evidence of inflammatory cell infiltration and new collagen deposition in the subconjunctiva. Immunohistochemistry assay showed that PCNA-expression was lower in the Group A (16.25 +/- 3.24%) compared to other groups (p<0.01). TUNEL assay showed a significant increase in the number of apoptotic fibroblasts around the surgical area in Group A and Group C (9.75 +/- 1.71% and 8.50 +/- 1.92%) compared to the Group B and D (p<0.01).Conclusions: Sirolimus drug sustained delivery film can inhibit inflammatory cell activity, impede fibroblast proliferation activity, and induce fibroblast apoptosis in the filtration surgery sites in rabbit. The results indicate a safe and effective treatment strategy in anti-scaring treatment in glaucoma surgery.

Anti-proliferative Effect of Olmesartan on Tenon's Capsule Fibroblasts.

Effects of Genistein on the Formation of Posterior Capsule Opacification

Losartan Attenuates Scar Formation in Filtering Bleb after Trabeculectomy.

Effects of atorvastatin on the function of Tenon's capsule fibroblasts in human eyes

SB-431542 Inhibition of Scar Formation after Filtration Surgery and Its Potential Mechanism.

The Effect of Topical Ramipril and Losartan Cream in Inhibiting Scar Formation

Anti-proliferation Effects of Sirolimus Sustained Delivery Film in Rabbit Glaucoma Filtration Surgery.

An experiment study on the prevention of scar formation of the filtering bleb by the application of anterior lens capsule in trabeculectomy with cataract surgery in rabbit eyes

Inhibition of the Rapamycin-Insensitive Mtorc1 /4E-BP1 Axis Attenuates TGF-β1-induced Fibrotic Response in Human Tenon's Fibroblasts

Inhibitory effect of tetrandrine on the apoptosis of cultured human Tenon's capsule fibroblasts

Angiotensin II As a Morphogenic Cytokine Stimulating Fibrogenesis of Human Tenon's Capsule Fibroblasts.

Inhibition of Cell Proliferation of Tenon's Capsule Fibroblast by S-phase Kinase-Interacting Protein 2 Targeting SiRNA Through Increasing P27 Protein Level.

Effect of Topical Losartan in the Treatment of Established Corneal Fibrosis in Rabbits

Niclosamide inhibits TGF-β1-induced fibrosis of human Tenon's fibroblasts by regulating the MAPK-ERK1/2 pathway

Anti-conjunctival bleb fibrosis effect of tetrandrine eye drop in rabbits after filtration surgery

Inhibition of Post-Trabeculectomy Fibrosis Via Topically Instilled Antisense Oligonucleotide Complexes Co-Loaded with Fluorouracil.

Effects of Honghua Preserved Amniotic Membrane on Scar Healing in Experimental Glaucoma Surgery

Inhibition of LPA1 Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing TGF-β/Smad2/3 Signaling

The Effects of Tranilast on the Proliferation and Migration of Human Tenon's Capsule Fibroblasts

Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA.

Induction of TGF-β1 on proliferation of Tenon's capsule fibroblasts and expression of connective tissue growth factor